Sales of the OTC antipyretic analgesic ‘Tylenol’ have soared. With the increased demand among people receiving the COVID-19 vaccinations, Tylenol sold ₩43.6 billion in the first half of this year, which is twice more than that sold in the whole term of last year. There has been criticism that the government’s recommendation to take Tylenol in the early phases of inoculation has promoted sales of specific brands.

According to the pharmaceutical research institution IQVIA on the 23rd, sales of Tylenol Tab. and Tylenol 8 hours ER Tab. had sold 139.6% more year-on-year to record ₩43.6 billion in the first half of this year. Tylenol’s sales increased 167.9% YOY to record ₩33.6 billion, and